The investigational new drug application--who benefits?

Nat Clin Pract Oncol. 2006 Feb;3(2):62-3. doi: 10.1038/ncponc0429.
No abstract available

MeSH terms

  • Academic Medical Centers
  • Antineoplastic Agents / therapeutic use*
  • Ethics Committees, Research / ethics
  • Government Regulation
  • Human Experimentation / ethics
  • Human Experimentation / legislation & jurisprudence*
  • Humans
  • Investigational New Drug Application / legislation & jurisprudence*
  • Neoplasms / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents